Sheetz MJ, Aiello LP, Davis MD, Danis R, Bek T, Cunha-Vaz J, Shahri N, Berg PH; MBDL and MBCU Study Groups (Lopez-Gálvez MI). The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies. Invest Ophthalmol Vis Sci. 2013; 54(3):1750-7. doi: 10.1167/iovs.12-11055. IF: 3.441.

Volver a Centro Lector: IOBA-RC: Experiencia investigadora y comunicaciones científicas